000 | 00902 a2200241 4500 | ||
---|---|---|---|
005 | 20250517193005.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.21136 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLv, Wan-Qi | |
245 | 0 | 0 |
_aGene editing of the extra domain A positive fibronectin in various tumors, amplified the effects of CRISPR/Cas system on the inhibition of tumor progression. _h[electronic resource] |
260 |
_bOncotarget _cDec 2017 |
||
300 |
_a105020-105036 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aWang, Hai-Cheng | |
700 | 1 | _aPeng, Jing | |
700 | 1 | _aWang, Yi-Xiang | |
700 | 1 | _aJiang, Jiu-Hui | |
700 | 1 | _aLi, Cui-Ying | |
773 | 0 |
_tOncotarget _gvol. 8 _gno. 62 _gp. 105020-105036 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.21136 _zAvailable from publisher's website |
999 |
_c27932389 _d27932389 |